Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry.
作者信息
van Westrhenen R, Ingelman-Sundberg M
机构信息
Parnassia Psychiatric Institute, Amsterdam, Netherlands.
Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands.
出版信息
Front Pharmacol. 2021 Sep 22;12:725565. doi: 10.3389/fphar.2021.725565. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry.
Front Pharmacol. 2021 Sep 22;12:725565. doi: 10.3389/fphar.2021.725565. eCollection 2021.
2
[Pharmacogenetics/pharmacogenomics in psychiatry].
Nihon Rinsho. 2010 Jan;68(1):155-62.
3
Pharmacogenomics: an Update for Child and Adolescent Psychiatry.
Curr Psychiatry Rep. 2020 May 6;22(5):26. doi: 10.1007/s11920-020-01145-4.
4
Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?
CNS Spectr. 2008 Feb;13(2):115-8. doi: 10.1017/s1092852900016254.
5
A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe.
World J Biol Psychiatry. 2017 Feb;18(1):29-38. doi: 10.3109/15622975.2016.1149219. Epub 2016 Apr 6.
6
Psychopharmacology and pharmacotherapy in psychiatry.
Psychosomatics. 1972 May-Jun;13(3):203-5. doi: 10.1016/S0033-3182(72)71437-1.
7
[Modern pharmacotherapy in psychiatry].
Med Klin. 1962 Jan 19;57:90-5.
8
[SOME COMMENTS ON PHARMACOTHERAPY IN PSYCHIATRY].
Postepy Hig Med Dosw. 1964 Nov-Dec;18:965-7.
9
[On central nervous decompensation in psychiatric pharmacotherapy as a contribution to experimental psychiatry].
Fortschr Neurol Psychiatr Grenzgeb. 1963 Mar;31:160-75.
10
From the lab to the prescription pad: genetics, CYP450 analysis, and medication response.
J Child Adolesc Psychiatr Nurs. 2013 May;26(2):119-23. doi: 10.1111/jcap.12028.
引用本文的文献
1
Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression.
Neurosci Appl. 2024 Jan 22;3:103937. doi: 10.1016/j.nsa.2024.103937. eCollection 2024.
2
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management.
Health Serv Insights. 2025 Jul 12;18:11786329251356560. doi: 10.1177/11786329251356560. eCollection 2025.
3
Effect of , , and Variation on Antipsychotic Treatment Outcomes.
Pharmaceuticals (Basel). 2025 Jun 14;18(6):892. doi: 10.3390/ph18060892.
4
PSY-PGx: a new intervention for the implementation of pharmacogenetics in psychiatry.
World Psychiatry. 2025 Feb;24(1):141-142. doi: 10.1002/wps.21289.
5
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants.
Eur J Hum Genet. 2024 Nov;32(11):1371-1377. doi: 10.1038/s41431-024-01648-1. Epub 2024 Jul 2.
6
A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study.
Pharmaceuticals (Basel). 2024 Jan 23;17(2):151. doi: 10.3390/ph17020151.
7
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Eur J Hum Genet. 2024 Mar;32(3):278-285. doi: 10.1038/s41431-023-01347-3. Epub 2023 Mar 31.
8
The WPA Scientific Sections: a global resource for education, research and care.
World Psychiatry. 2022 Oct;21(3):474-475. doi: 10.1002/wps.21011.
本文引用的文献
1
Economic evaluation in psychiatric pharmacogenomics: a systematic review.
Pharmacogenomics J. 2021 Aug;21(4):533-541. doi: 10.1038/s41397-021-00249-1. Epub 2021 Jul 2.
2
Pharmacogenetics-Guided Advances in Antipsychotic Treatment.
Clin Pharmacol Ther. 2021 Sep;110(3):582-588. doi: 10.1002/cpt.2339. Epub 2021 Aug 18.
3
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram.
Clin Pharmacol Ther. 2021 Sep;110(3):786-793. doi: 10.1002/cpt.2233. Epub 2021 Apr 13.
4
How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Front Genet. 2020 Dec 8;11:491895. doi: 10.3389/fgene.2020.491895. eCollection 2020.
5
Pharmacogenetics at Scale: An Analysis of the UK Biobank.
Clin Pharmacol Ther. 2021 Jun;109(6):1528-1537. doi: 10.1002/cpt.2122. Epub 2020 Dec 17.
6
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
JAMA Psychiatry. 2021 Mar 1;78(3):270-280. doi: 10.1001/jamapsychiatry.2020.3643.
7
Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
Transl Psychiatry. 2020 Jun 19;10(1):198. doi: 10.1038/s41398-020-00888-1.
8
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
Front Psychiatry. 2020 Mar 12;11:94. doi: 10.3389/fpsyt.2020.00094. eCollection 2020.
9
Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements.
Clin Pharmacol Ther. 2020 May;107(5):1240-1255. doi: 10.1002/cpt.1720. Epub 2019 Dec 17.
10
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
Lancet Psychiatry. 2019 May;6(5):418-426. doi: 10.1016/S2215-0366(19)30088-4. Epub 2019 Apr 15.
Zotero 插件